Canaccord Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Go back to Canaccord Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 266.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $266.99 | 52 Week High | $109.10 | |||
| Open | $266.99 | 52 Week Low | $31.38 | |||
| Day High | $266.99 | P/E | N/A | |||
| Day Low | $266.99 | EPS | $-1.45 | |||
| Volume | 1,381 | |||||
